APYX Apyx Medical Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: APYX

Price (delayed)

$1.44

Market cap

$49.89M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.54

Enterprise value

$44.74M

Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people's lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium ...

Highlights
The quick ratio has surged by 157% year-on-year and by 32% since the previous quarter
The revenue is up by 18% year-on-year and by 4.1% since the previous quarter
The EPS has declined by 26% since the previous quarter but it rose by 19% year-on-year
APYX's net income is down by 23% since the previous quarter but it is up by 19% year-on-year
APYX's debt has soared by 168% QoQ
APYX's equity is down by 29% year-on-year and by 20% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://apyxmedical.com
Peers: NVRO OFIX NURO

Key stats

What are the main financial stats of APYX
Market
Shares outstanding
34.64M
Market cap
$49.89M
Enterprise value
$44.74M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.87
Price to sales (P/S)
0.95
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.85
Earnings
Revenue
$52.35M
EBIT
-$18.67M
EBITDA
-$17.89M
Free cash flow
$1.49M
Per share
EPS
-$0.54
Free cash flow per share
$0.04
Book value per share
$0.77
Revenue per share
$1.51
TBVPS
$2.29
Balance sheet
Total assets
$79.24M
Total liabilities
$52.32M
Debt
$38.5M
Equity
$26.7M
Working capital
$57.62M
Liquidity
Debt to equity
1.44
Current ratio
5.52
Quick ratio
4.53
Net debt/EBITDA
0.29
Margins
EBITDA margin
-34.2%
Gross margin
64.5%
Net margin
-35.7%
Operating margin
-38.1%
Efficiency
Return on assets
-29%
Return on equity
-56.4%
Return on invested capital
-43%
Return on capital employed
-28.1%
Return on sales
-35.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

APYX stock price

How has the Apyx Medical stock price performed over time
Intraday
-2.7%
1 week
9.09%
1 month
12.5%
1 year
-51.02%
YTD
-45.04%
QTD
5.88%

Financial performance

How have Apyx Medical's revenue and profit performed over time
Revenue
$52.35M
Gross profit
$33.76M
Operating income
-$19.95M
Net income
-$18.71M
Gross margin
64.5%
Net margin
-35.7%
APYX's net margin is up by 31% YoY but it is down by 19% QoQ
Apyx Medical's operating margin has increased by 28% YoY and by 4.8% QoQ
APYX's net income is down by 23% since the previous quarter but it is up by 19% year-on-year
The revenue is up by 18% year-on-year and by 4.1% since the previous quarter

Growth

What is Apyx Medical's growth rate over time

Valuation

What is Apyx Medical stock price valuation
P/E
N/A
P/B
1.87
P/S
0.95
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.85
The EPS has declined by 26% since the previous quarter but it rose by 19% year-on-year
The price to book (P/B) is 53% lower than the 5-year quarterly average of 4.1 and 47% lower than the last 4 quarters average of 3.6
APYX's equity is down by 29% year-on-year and by 20% since the previous quarter
The stock's price to sales (P/S) is 84% less than its 5-year quarterly average of 6.3 and 61% less than its last 4 quarters average of 2.5
The revenue is up by 18% year-on-year and by 4.1% since the previous quarter

Efficiency

How efficient is Apyx Medical business performance
The return on invested capital is up by 46% year-on-year and by 5% since the previous quarter
Apyx Medical's return on equity has decreased by 34% QoQ and by 6% YoY
The return on sales rose by 30% year-on-year but it has declined by 11% since the previous quarter
The company's return on assets rose by 28% YoY but it fell by 10% QoQ

Dividends

What is APYX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for APYX.

Financial health

How did Apyx Medical financials performed over time
The total assets is 51% more than the total liabilities
The quick ratio has surged by 157% year-on-year and by 32% since the previous quarter
Apyx Medical's total liabilities has surged by 102% QoQ
APYX's debt is 44% higher than its equity
APYX's debt has soared by 168% QoQ
APYX's equity is down by 29% year-on-year and by 20% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.